Research Paper Volume 16, Issue 3 pp 2563—2590
Integrative analysis confirms TPX2 as a novel biomarker for clinical implication, tumor microenvironment, and immunotherapy response across human solid tumors
Figure 1. Expression level and diagnostic value of TPX2 in pan-cancer from the TCGA database. (A) Boxplot of the mRNA expression of TPX2 in 31 solid cancer types from the TCGA database. Expression level of TPX2 was presented as FPKM. (B) ROC curve analyses to determine the diagnostic value of TPX2 in the TCGA database. *p< 0.05, **p< 0.01, ***p< 0.001.